• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Aurobindo Pharma Limited — Board Meeting, 09-02-2026: Outcome of Board Meeting

    09-02-2026 | 07:33 pm

    Aurobindo Pharma announced strong Q3 consolidated results: Revenue at ₹8,645.9 Cr & PAT at ₹909.8 Cr. Strategic moves include a ₹325 Cr acquisition of Khandelwal Labs' non-oncology business and plans to acquire Lannett Company LLC.

    No comments yet. Be the first to comment!

    All announcements from Aurobindo Pharma Limited